Drug-induced pulmonary disease.
Pulmonary disorders appearing as manifestations of adverse reactions to medications administered orally or parenterally are reviewed. The mechanisms involve toxicity, idiosyncrasy, allergy, or a combination. The drugs and medications include commonly used antimicrobial, antineoplastic, analgesic, vasoactive, neuroactive, and endocrine agents. For most reactions, the mechanisms are unidentified.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000700:Analgesics / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D004205:Cromolyn Sodium / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D008784:Methysergide / Q000009:adverse effects; D008875:Middle Aged; D009582:Nitrofurantoin / Q000009:adverse effects; D011433:Propranolol / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000700:Analgesics; D000890:Anti-Infective Agents; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D009582:Nitrofurantoin; D011433:Propranolol; D004205:Cromolyn Sodium; D008784:Methysergide